Abstract
One of Pfizer Pharmaceutical’s general corporate goals is that no person anywhere should be restricted from receiving essential and affordable medicines. From 2009 to 11 Pfizer’s internal corporate social responsibility (csr) programmes were private corporate efforts that were discretionary and limited in scope and impact. All Pfizer’s csr preferred public policy governmental positions encompassed neoliberal government requirements based on market and profit considerations, with no positions demonstrating, in detail, how universal provision of drugs for all would be provided. Currently Pfizer’s csr efforts represent a dichotomy when compared with the general corporate goal of not restricting essential and affordable medicines in order to provide medicines for all.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.